PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

(Dr Explains) 8 Signs You're Taking Too Much Ozempic, Mounjaro, or Zepbound!

Clinician15:32May 2026

Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The speaker, a board-certified internal medicine physician and medical director, says many new patients come to him after severe side effects on GLP-1 medications. He attributes this to prescribers who raise the dose every 4 weeks by default, following the standard schedules from Eli Lilly and Novo Nordisk, even when there is no reason to. The video lists eight signs he says may point to a dose that is too high, and he stresses these are prompts for a conversation with a provider, not an instruction to change the dose right away.

Published by Dr. Kevin Joseph, DO on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

The first signs are neurological and mood related. He describes anhedonia (loss of pleasure from things that used to be enjoyable) and allodynia (pain from normally painless touch, such as bed sheets or clothing). He says both seem dose-dependent, and that he has seen patients improve after lowering the dose or switching between semaglutide and tirzepatide. He then covers nausea, which he says is more common on semaglutide than tirzepatide, and explains why he favors microdosing. Extreme fatigue and insomnia follow, with his suggestions about dose timing.

The last signs are very low food intake, dehydration, and hypoglycemia. He says patients should still reach a minimum calorie goal, and that a dose which prevents this is too high for them. He advises attention to water and electrolytes, and says people on insulin or a sulfonylurea may need those drugs reduced rather than the GLP-1. His closing view is that the best dose gives clinical benefit with minimal to no side effects. Everything here is the speaker's opinion and clinical experience, not medical advice.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The speaker says many side effects he sees come from providers raising the dose every 4 weeks by default.
  2. 2:02 He says anhedonia, a loss of enjoyment from activities, appears dose-dependent and may improve with a lower dose or a switch between semaglutide and tirzepatide.
  3. 3:35 He describes allodynia, pain from light touch, as rare with semaglutide and tirzepatide and most likely at the highest doses.
  4. 5:07 He says nausea is more common on semaglutide and often improves on tirzepatide, and he supports microdosing to reduce side effects.
  5. 7:40 He links extreme fatigue and insomnia to high doses and suggests changing injection timing, evening for fatigue and morning for insomnia.
  6. 10:40 He recommends hitting a minimum calorie goal, watching hydration and electrolytes, and asking about lowering insulin rather than the GLP-1 if blood sugar runs low.

Key moments

Tap one to play from there.

  1. 0:00 Introduction
  2. 2:00 Anhedonia
  3. 3:45 Allodynia
  4. 5:15 Nausea
  5. 7:31 Extreme fatigue
  6. 9:28 Insomnia
  7. 10:38 Not eating enough
  8. 12:17 Dehydration

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic, Zepbound, Mounjaro and semaglutide
Side effects mentioned
nausea, vomiting, fatigue, dizziness and dehydration

Questions this video answers

How do I know if my Ozempic or Mounjaro dose is too high?

The speaker lists eight possible signs: anhedonia, allodynia, nausea, extreme fatigue, insomnia, very low food intake, dehydration, and low blood sugar. He says these are reasons to talk with your provider, not necessarily to change the dose immediately.

Can GLP-1 medications cause both fatigue and insomnia?

According to the speaker, yes. He says some patients are very tired all day yet cannot fall asleep at night. For fatigue he suggests asking about a lower dose or an evening injection, and for insomnia without daytime fatigue he suggests a morning dose and the lowest dose possible.

Does Zepbound cause less nausea than Ozempic?

The speaker says that, in his clinical experience, nausea and vomiting are significantly more common on semaglutide products like Ozempic or Wegovy. He says adding the GIP agonist effect in tirzepatide products like Zepbound or Mounjaro improves GI symptoms, and he suggests discussing a switch with your provider.

Can GLP-1 medications cause low blood sugar?

He says GLP-1s act in a glucose-dependent way, so the risk mainly arises with a sulfonylurea or insulin. For symptoms like shakiness, sweating or confusion, he suggests asking the provider to lower insulin and other diabetes medications rather than the GLP-1.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Zepbound side effects: the label's table by dose, who actually quits, and how it compares to semaglutide

    Zepbound's label puts a number on every common side effect at each of its three maintenance doses. Nausea runs 25 to 29 percent against 8 on placebo, diarrhoea 19 to 23, vomiting 8 to 13, constipation 11 to 17. Across the two approval trials, 4.8 to 6.7 percent of people stopped the drug because of side effects, against 3.4 percent on placebo, and most of those who quit did so in the first months, from gut effects during dose escalation. Below that table are the rarer things the label warns about, with the trial rates where it gives them, and the honest comparison to Ozempic's table.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

  • Stopping a GLP-1: what the withdrawal trials found, and what a maintenance dose actually is

    Two trials have measured what happens when you stop. On semaglutide, people who lost 17.3% over 68 weeks regained two-thirds of it in the year after stopping, ending 5.6% below where they started. On tirzepatide, people who lost 20.9% in 36 weeks regained 14% over the next year on placebo while those who continued lost a further 5.5%. Both labels are explicit that these drugs are for maintaining weight reduction long term, which is a different claim from finishing a course. A maintenance dose is simply the dose you stay on; the labels do not define a lower one to step down to at goal.

Next steps

Ozempic prices

Insurance

Find more like it

Side effectsDose changeFood noise and cravingsStopping and maintenanceHow it worksThe trialsNauseaVomitingFatigueDizziness

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV